Glioblastoma
RecruitingStudy on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients
- Disease:Glioblastoma
- Substances:Temozolomide
Norway- Participants:18–64 years · 65+ years
- Substances:Temozolomide
- Sponsor:Region Oestergoetland
Rare diseases
Investigational molecules
Locations
Back to Norway40 clinical trials in Kristiansand, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
NorwayThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on precision cancer medicine for various types of malignancies, including studies on rare cancers and targeted therapies.
Studies evaluating novel drug combinations and biomarker-driven treatment approaches.
Research focusing on advanced treatments for ovarian and endometrial cancers, investigating maintenance therapies and immunotherapy combinations.
Evaluating targeted therapies and novel treatment combinations for improved patient outcomes.
Studies addressing various neurological disorders, including glioblastoma treatment and stroke management protocols.
Investigating innovative therapeutic approaches and combination treatments.
Clinical research examining treatments for rheumatoid arthritis and immune-related conditions, focusing on therapeutic drug monitoring.
Evaluating treatment efficacy and monitoring strategies for improved patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.